News

News from the lab at the Northwestern University (2020-present)

  • Dr. Adli delivered a keynote address at the TBS International Laboratory Medicine Summit 2025. (November 2025)
  • We welcome Yasemin Tekin (Research Specialist) and Brittany Johnson (DGP Graduate Student) to our lab. (September 2025)
  • We are thrilled to congratulate Ozlem Neyisci on beginning her PhD in Northwestern’s DGP Program!
  • Dr. Adli visited the University of Chicago as a guest lecturer, presenting on screening and reengineering the genome to characterize all human genes. (August 2025)
  • Congratulations to Alexander Duval on successfully defending his PhD dissertation! We’re proud of his hard work and excited to see what’s next in his scientific journey. (June 2025)
  • Dr. Adli delivered the opening keynote at the X. Multidisciplinary Cancer Research Congress, organized by MOKAD, and was honored as Cancer Researcher of the Year. (May 2025)
  • De Xing, Ozlem Neyisci and Bervis Hemis presented the lab’s work on characterizing essential human genes at the annual MorPhiC Consortium Meeting in San Francisco. (February 2025)
  • At the SLAS Conference, Dr. Adli presented the lab’s CRISPR screening and high-throughput genome engineering work in induced pluripotent stem cells. (January 2025)
  • During a visit to the Qatar Biomedical Research Institute (QBRI), Dr. Adli discussed recent developments in the field and shared updates on the lab’s ongoing research. (December 2024)
  • Dr. Adli delivered the opening keynote at the 8th Epigenetic Symposium, hosted by the University of Wisconsin–Madison. (November 2024)
  • Heartfelt congratulations to Dr. Adli on being named Thomas J. Watkins Endowed Professor of Cancer Genomics at Northwestern University!
  • We welcome Bervis Hemis as she joins our lab as a Research Technologist. (August 2024)
  • Zhonglin Li joins our lab as Postdoctoral Researcher.
  • At Fibroid Summit 2023, Dr. Adli presented the lab’s recent work on modeling fibroid-driving MED12 mutations through genetic engineering.
  • The lab’s work was highlighted by Dr. Adli at the 2023 Bioengineering Approaches in Cancer & Development Symposium.
  • Dr. Adli spoke on the Breakthroughs podcast about recent discoveries in the lab and our MORPHIC consortium grant.
  • Dr. Adli was interviewed by The Independent-Turkish about the discovery of ISL2 as a novel tumor suppressor of pancreatic cancer.
  • We wholeheartedly welcome De Xing (postdoc), Tao Bai (lab manager), Ozlem Neyisci (Research Tech), Gina Kirsammer (program manager) and Fatih Abdula (visiting scholar) to join the lab (September 2022) 
  • Adli Lab is awarded a second NCI R01 to study the mechanism of chemoresistance in Ovarian Cancer (September 2022). 
  • Adli lab is awarded the NHGRI Morphic consortium UM1 grant (September 2022). We will use degron system to characterize essential human genes in iPSC.  
  • We discovered ISL2 gene as a novel tumor suppressor in pancreatic cancer (Developmental Cell (2022)).
  • Kadir Buyukcelebi joins the lab as a postdoctoral fellow (2021).
  • We welcome Fidan Seker as a postdoctoral fellow in the lab (2020).
  • Alex Duval and Harun Ozturk joined the Adli lab as DGP graduate students.
  • Adli lab has relocated to Chicago! We are now part of the Northwestern University, Feinberg School of Medicine, as of January 1st, 2020. We are very excited about this new beginning in the beautiful city of Chicago! (January 1st, 2020). 

News from University of Virginia (2012-2020)

  • Kudos to all the teams who contributed to the in vivo CRISPR screening papers for combinatorial drug screening (Nature Communications (2018) and PNAS (2020)).
  • Adli lab has been awarded an NSF grant to develop tools to manipulate and image chromatin structure and function (Aug, 2017)
  • Kudos to Cem! CRISPR-STOP is a new cool tool to silence genes by base editing. It is accepted for publication in Nature Methods (May, 2017)
  • Congratulations to all the fantastic team! CRISPR-chromatin imaging in living cell paper is now published in Nature Communications (April, 2017)
  • Adlilab has been awarded an RO1 grant by NCI to study chemoresistance-associated epigenomic aberrations in Ovarian Cancer (April, 2017)
  • Kudos to Ritambhara! The CROP-IT CRISPR off target prediction tool is published in Nucleic Acid Research (June, 2015).
  • Dr. Adli is named 2014 V Scholar , an award from V Cancer research foundation (Oct, 2014).
  • The very first manuscript from the Adlilab has been published in Nature Biotechnology (May, 2014).
  • February, 2015: Natasha Fisher joined the lab as Research technician.
  • October, 2014: Dr. Adli was granted V Scholar award from V Cancer Research Foundation.
  • May, 2014: the very first manuscript from the Adlilab by Kuscu & Arslan et al., has been accepted to Nature Biotechnology. Kudos to all the contributors!
  • April, 2014: Stephen Shang joined the lab as graduate student.
  • March, 2013: Prof. Sevki Arslan joined the lab as visiting scholar from Denizli University, Denizli/Turkey.
  • January 10th, 2013: Dr. Cem Kuscu joined the lab as postdoctoral research scientist
  • November 1st, 2012: The grand opening day for the Adli Lab !!! We had our very first lab meeting!!!
  • November, 2012: Ritambhara Singh joined the lab as graduate student from the Department of Computer Science!

News from Harvard Medical School/Broad Institute (2007-2012)